Beta We are building this new website to better deliver information. Learn more about this site. Learn more or
Corporate Plan 2018-2019

Prioritising mental health and preventive health

We aim to reduce the rates of preventable mortality and morbidity caused by chronic disease, substance misuse and other risk factors, such as tobacco use and dietary risks.  This will be achieved through evidence-based promotion of healthy lifestyles, early detection of cancer and other conditions, targeted education, increased immunisation, and reduced injuries from accidents. Further initiatives will be implemented to improve health outcomes for Aboriginal and Torres Strait Islander people and to improve the delivery and design of mental health support services and policies.

This initiative aligns to department outcomes 1, 2, 3 & 5 in the Health Portfolio Budget Statements

Our aim

  • Offer cost-effective pathways for people seeking help for mental health issues.
  • Prevent the spread of disease and promote higher vaccination uptake in at-risk populations.
  • Improve earlier diagnosis and treatment of Spinal Muscular Atrophy.
  • Better manage the impacts of endometriosis through earlier referral and best practice clinical care.
  • Help more Australians to receive lifesaving organ transplants.
  • Provide high quality information, expertise and support for people living with epilepsy.
  • Support earlier intervention and faster recovery for people affected by drug and alcohol abuse.
  • Improve prevention, early detection, treatment, and survival outcomes for people with cancer.

Our challenges

  • Information on mental health can be constrained by the availability of comparable national data on mental health. 
  • Increasing demand on health services continues to put pressure on existing health workforce and services. 
  • Public debate on immunisation has led to misinformation about vaccination.

Our work to achieve this initiative

  • Progressing key initiatives in mental health, suicide prevention, harmful alcohol consumption and drug use, and injury prevention.
  • Investing in maternal and infant health.
  • Delivering targeted education and strategies to improve understanding and awareness of specific areas of health.
  • Delivering targeted vaccination programs, including information about and extension of the Childhood Immunisation Education Campaign.
  • Improving early detection, treatment and survival outcomes for people with cancer.

Our role and that of our partners

  • We will continue to strengthen relationships with our stakeholders and work with local health providers and hospitals to improve services.
  • We will continue working with States and Territories to ensure a nationally consistent approach to achieving better health outcomes for all Australians.
  • We are supported by other departments who provide insight, advice, compliance and enforcement, administration of payments and/or services on our behalf to achieve our objectives including:
    • improving access to services and supports for people with psychosocial disability;
    • improving mental health and suicide prevention systems; and increasing immunisation coverage rates.

Management of identified risks

Key risks

Failure to sufficiently coordinate and integrate existing services to support people with, or at risk of, mental illness resulting in fragmented service offerings which patients and medical practitioners are unable to navigate.

Inability to reduce the incidence of vaccine preventable diseases through the National Immunisation Program and associated immunisation initiatives.

Management strategies

We will continue to invest and support key areas of need, such as mental health, infant health, and preventive health to make sure the community has the necessary services needed, when needed.

We will closely monitor arrangements and services provided through the Program and associated initiatives.

Measuring our performance against key measures

Performance measures

Mental health services are more coordinated and supported through the implementation of the Strengthening mental health care in Australia measure.
Target 2018–19

Support Primary Health Networks, service providers, and mental health stakeholders delivering mental health reforms by:

  • monitoring progress of Primary Health Network commissioning and delivery of mental health services, for example, the Way Back Support Service;
  • delivery of enhancements to ‘Head to Health’, including ensuring greater usability by health professionals;
  • transitioning of Partners in Recovery and Day to Day Living Programs into the National Disability Insurance Scheme;
  • supporting development of regional mental health and suicide prevention plans by Primary Health Networks and Local Hospital Networks, under the auspices of the Fifth National Mental Health and Suicide Prevention Plan;
  • continued establishment of new headspace services in rural and regional areas; and
  • commencement of Mental Health in Education initiative in schools and early learning services.
Target 2019–22

Support Primary Health Networks, service providers, and mental health stakeholders delivering mental health reforms by ongoing monitoring of progress of Primary Health Network commissioning and delivery of mental health services.

National direction supports a collaborative approach to preventing and reducing the harms from alcohol, tobacco and other drugs. 
Target 2018–19

Continue investment in quality alcohol and drug treatment services.

Continue to build the evidence base in relation to alcohol and drugs through high quality research.

Work with states and territories, and other relevant agencies to:

Target 2019–22

As per 2018–19

Improving prevention, early detection, treatment and survival outcomes for people with cancer.
Target 2018–19

Increase in the percentage of people participating in the National Bowel Cancer Screening Program to 53.1 per cent by December 2019. [1]

The percentage of women 50–74 years of age participating in BreastScreen Australia is maintained at 54 per cent. [2] 

The percentage of women in the target age group (20–69 years) participating in the National Cervical Screening Program is maintained at 57 per cent. [3] [4] 

Target 2019–22

Increase participation to 56.6 per cent and maintain participation at this rate through to 2022.

Maintain participation at 54 per cent.

Maintain participation at 57 per cent.

Increasing national immunisation coverage rates and improving the effectiveness of the National Immunisation Program.
Target 2018–19

Immunisation coverage rates in children at 5 years of age are increased to ≥ 94.25 per cent.

Immunisation coverage rates among 12–15 month old Aboriginal and Torres Strait Islander children are increased to ≥ 92.50 per cent.

Target 2019–22

Increase immunisation coverage rates to ≥ 94.50 per cent and by 0.25 per cent per year until 2022.

Increase immunisation coverage rates to ≥ 93.00 per cent and by 0.50 per cent per year until 2022.

Health outcomes of Aboriginal and Torres Strait Islander people are improved through implementing actions under the Implementation Plan for the National Aboriginal and Torres Strait Islander Health Plan 2013–2023.
Target 2018–19

Release revised iteration of the Implementation Plan

Continue work towards achieving the identified deliverables and goals for 2023 as specified in the Implementation Plan.

Engage with the Implementation Plan Advisory Group, other Commonwealth agencies, Council of Australian Governments Health Council and its subcommittees, Health Partnership Forums and the Indigenous health sector to progress Implementation Plan activities, including those on the social determinants of health.

Target 2019–22

Progress against the Implementation Plan continues to be monitored and reviewed through the Implementation Plan Advisory Group and the Aboriginal and Torres Strait Islander Health Performance Framework.

  • 1 Participation is defined as the percentage of people invited to screen through the National Bowel Cancer Screening Program over a two year period (1 January to 31 December) who return a completed screening test within that period or by 30 June of the following year.
  • 2 Participation in the BreastScreen Australia Program has remained stable over the past five years. The ongoing participation trend is expected to remain stable over the forward years.
  • 3 From 1 December 2017, the two yearly Pap test for women 18 to 69 years of age changed to a five yearly Human Papillomavirus test for women 25 to 74 years of age.
  • 4 Data is not available to forecast forward year targets. Targets will be updated following implementation of the renewal of the National Cervical Screening Program and the National Cancer Screening Register. 
Last updated: 
31 August 2018